BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine

Biopharma in 2025: AI Transforming Drug Discovery and Precision Medicine The biopharma landscape in 2025 is poised for an unprecedented transformation, dr...

December 13, 2024 | Analysis

Everest Medicines Announces First Prescription of VELSIPITY® for Ulcerative Colitis in Macau, Marking a Key Milestone in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

December 13, 2024 | News

GHIT Fund and WHO Strengthen Partnership to Combat Neglected Tropical Diseases

The Global Health Innovative Technology (GHIT) Fund and the World Health Organization (WHO) have signed a memorandum of understanding (MoU) to furthe...

December 11, 2024 | News

Terumo and Medis Partner to Advance Cardiovascular Care

Collaboration combines Terumo's ePRISM™ precision medicine software platform with Medis' QFR® technology – Terumo Health Ou...

December 11, 2024 | News

SNUBH, CurePSP, and GemVax Unite to Establish Korea’s First International PSP Research and Treatment Center

MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center Tackling Global Challenges in an Aging Er...

December 10, 2024 | News

myTomorrows Expands to APAC with New India Hub to Transform Access to Pre-Approval Treatments

Drawing on its extensive experience connecting physicians and patients to different treatment options, myTomorrows will address challenges in accessing tre...

December 09, 2024 | News

Alamar Biosciences Expands to APAC with ARGO™ HT System Installation at HKCeND

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence in th...

December 09, 2024 | News

Caliway Biopharma Joins Prestigious FTSE TWSE Indices, Reinforcing Global Biotech Leadership

Caliway Biopharmaceuticals Co., Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE T...

December 09, 2024 | News

Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production

The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity&nb...

December 06, 2024 | News

GE HealthCare Introduces Deep Learning Imaging Solutions to Enhance Diagnostics

More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare an...

December 06, 2024 | News

NTC Announces Positive Phase II Results for NTC014 in Bacterial Conjunctivitis Treatment

NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a mul...

December 06, 2024 | News

Field Medical's FieldForce™ Ablation System Secures FDA Breakthrough Status

First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from vent...

December 06, 2024 | News

AC Health Partners with USAID to Expand Stigma-Free HIV Care in the Philippines

Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector's eff...

December 04, 2024 | News

CBC Group and Mubadala Acquire UCB’s Neurology and Allergy Business in China for $680M

CBC Group and Mubadala acquire UCB’s mature neurology and allergy business in China for US$680 million. New company is named NeuroGen ...

December 02, 2024 | News

Stay Connected